Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

SciClone gets rights to APR's RapidFilm ondansetron

Executive Summary

SciClone Pharmaceuticals (cancer and infectious diseases) has licensed exclusive Chinese commercialization rights to APR Applied Pharma Research SA's (drug delivery and medical devices) RapidFilm formulation of the supportive oncology therapy ondansetron.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register